Literature DB >> 20089354

Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals.

Dunne Fong1, Arthur Yeh, Rotem Naftalovich, Theresa Hyejeong Choi, Marion M Chan.   

Abstract

The phytochemical curcumin, from the Indian spice turmeric, has many biological properties, including anti-inflammatory and anti-carcinogenic activities. We have examined the effects of curcumin on the rat C6 glioma cell line. Treated and control cells were analyzed by Hoechst 33342 dye and flow cytometry. We observed a decrease in the side population (SP) of C6 cells after daily curcumin treatment of the C6 cells. Direct incubation of curcumin to C6 cells during the Hoechst assay also decreased SP. Since SP has been associated with stem cell populations, curcumin may be a dietary phytochemical with potential to target cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089354      PMCID: PMC2862867          DOI: 10.1016/j.canlet.2009.12.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  55 in total

1.  Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters.

Authors:  Federica Montanaro; Kalliopi Liadaki; Jaclyn Schienda; Alan Flint; Emanuela Gussoni; Louis M Kunkel
Journal:  Exp Cell Res       Date:  2004-08-01       Impact factor: 3.905

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  Induction of HSP70 gene expression by modulation of Ca(+2) ion and cellular p53 protein by curcumin in colorectal carcinoma cells.

Authors:  Y C Chen; T C Kuo; S Y Lin-Shiau; J K Lin
Journal:  Mol Carcinog       Date:  1996-12       Impact factor: 4.784

4.  Flow cytometry of the Side Population: tips & tricks.

Authors:  Irene Sales-Pardo; Ariadna Avendaño; Vanessa Martinez-Muñoz; Marta García-Escarp; Raquel Celis; Phil Whittle; Jordi Barquinero; Joan Carles Domingo; Pedro Marin; Jordi Petriz
Journal:  Cell Oncol       Date:  2006       Impact factor: 6.730

Review 5.  Cancer stem cells and brain tumors: uprooting the bad seeds.

Authors:  Da Yong Lee; David H Gutmann
Journal:  Expert Rev Anticancer Ther       Date:  2007-11       Impact factor: 4.512

Review 6.  ALDH1 as a functional marker of cancer stem and progenitor cells.

Authors:  Julie Douville; Raymond Beaulieu; Danuta Balicki
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

7.  Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.

Authors:  Byeong Hyeok Choi; Chang Gun Kim; Yoongho Lim; Soon Young Shin; Young Han Lee
Journal:  Cancer Lett       Date:  2007-11-19       Impact factor: 8.679

Review 8.  Stem cell-like cancer cells in cancer cell lines.

Authors:  Toru Kondo
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388

9.  Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice.

Authors:  Suneet Shukla; Hani Zaher; Anika Hartz; Björn Bauer; Joseph A Ware; Suresh V Ambudkar
Journal:  Pharm Res       Date:  2008-10-09       Impact factor: 4.200

Review 10.  The cancer stem cell hypothesis: in search of definitions, markers, and relevance.

Authors:  Michail Shipitsin; Kornelia Polyak
Journal:  Lab Invest       Date:  2008-03-31       Impact factor: 5.662

View more
  39 in total

Review 1.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

2.  Effects of NOTCH1 signaling inhibitor γ-secretase inhibitor II on growth of cancer stem cells.

Authors:  Xiaodong Ding; Changqing Ding; Fei Wang; Wenshuai Deng; Mingming Yu; Qinghai Meng; Peng Sun
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

3.  Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastoma.

Authors:  Gregor A Rodriguez; Ashish H Shah; Zachary C Gersey; Sumedh S Shah; Amade Bregy; Ricardo J Komotar; Regina M Graham
Journal:  Ther Adv Med Oncol       Date:  2016-04-25       Impact factor: 8.168

4.  Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.

Authors:  Xin-xing Li; Ying Dong; Wei Wang; Hao-lu Wang; Yu-ying Chen; Gui-ying Shi; Jing Yi; Jian Wang
Journal:  Stem Cells Dev       Date:  2012-11-07       Impact factor: 3.272

5.  A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.

Authors:  Kah Jing Lim; Savita Bisht; Eli E Bar; Anirban Maitra; Charles G Eberhart
Journal:  Cancer Biol Ther       Date:  2011-03-01       Impact factor: 4.742

6.  Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma.

Authors:  Ping Lu; Hefen Sun; Lixing Zhang; Helei Hou; Lin Zhang; Fangyu Zhao; Chao Ge; Ming Yao; Tingpu Wang; Jinjun Li
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

7.  CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.

Authors:  Sayantan Bhattacharyya; Vasanthakumar Sekar; Biswanath Majumder; Debapriya G Mehrotra; Samir Banerjee; Anup K Bhowmick; Neyaz Alam; Gautam K Mandal; Jaydip Biswas; Pradip K Majumder; Nabendu Murmu
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

8.  Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.

Authors:  Ece Gülçür; Mentor Thaqi; Fatima Khaja; Antonina Kuzmis; Hayat Önyüksel
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 9.  Therapeutic strategies targeting cancer stem cells.

Authors:  Xiaoyan Ning; Jianchang Shu; Yiqi Du; Qiwen Ben; Zhaoshen Li
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

10.  Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.

Authors:  Xiaoyan Ning; Yiqi Du; Qiwen Ben; Ling Huang; Xiaoping He; Yanfang Gong; Jun Gao; Hongyu Wu; Xiaohua Man; Jing Jin; Ming Xu; Zhaoshen Li
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.